Crossmark

(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway

Crossref DOI link: https://doi.org/10.1186/s12906-015-0566-y

Published Online: 2015-03-24

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shen, Yi

Jiang, Ting

Wang, Rongsheng

He, Shijun

Guo, Mengru

Zuo, Jianping

He, Dongyi
License Information

License valid from 2015-03-24
More Information

Article History

Received: 22 August 2014

Accepted: 19 February 2015

First Online: 24 March 2015